iShares U.S. Pharmaceuticals ETF (IHE)

173.89
Delayed Data
As of 3:33pm ET
 +1.02 / +0.59%
Today’s Change
115.53
Today|||52-Week Range
175.67
+8.59%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.

No recent news for iShares U.S. Pharmaceuticals ETF.

Performance

1 month+8.00% 3 years+5.20%
3 months+4.69% 5 years+2.33%
1 year+15.71% Since inception+10.39%
Data through 12/02/2020

Quote Details

Previous close$172.87
Open day’s range173.89 – 173.89
Net asset value (NAV)172.37 (12/01/2020)
Daily volume5,619
Average volume (3 months)10,174
Data as of 3:33pm ET, 12/03/2020

Peer Comparisonvs. Health ETFs

 IHECategory
Performance 5-yr return+2.33%+10.93%
Expense Gross exp ratio0.42%1.21%
Risk 5 year sharpe ratio0.130.50
Net assets$343.1M$3.5B
Average market cap$45.7B$37.8B
Average P/E24.424.6
Dividend / Share--0.27%

Competitors

VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
IHI iShares U.S. Medical Devices ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson21.06%
MRK Merck17.71%
-- 4.91%
CTLT Catalent Inc4.76%
HZNP Horizon Therapeutics PLC4.75%
ZTS Zoetis Inc4.59%
BMY Bristol-Myers Squibb4.55%
PFE Pfizer4.51%
ELAN Elanco Animal Health Inc4.20%
LLY Eli Lilly and Co3.95%